Intraoperative Visualization of Large Head and Neck Tumors to Optimize Radiation Therapy Planning Using Liquid Soft-tissue Markers Such as BioXmark® (During Definitive Treatment or in the Postoperative Setting)

Brief summary (registry, in English)

The aim of this study is to find out how well BioXmark® can help the investogators to see the tumor area in patients with head and neck cancer. The Investigators want to use this information to better define the area that needs radiation treatment. This may helpt he Investigators treat the tumor more precisely and protect healthy tissue around it. This could reduce side effects from radiation. The Investigators also want to find out whether different types of head and neck tumors can be seen equally well with BioXmark®. During and after treatment, the Investigators will also look at possible side effects and how well important functions are maintained.

What you commit to

• Study type: Interventional
• Planned participants: 295
• From 1 Sept 2026 to the primary completion date, 31 Oct 2034
• No sites listed in no country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov